Hemophagocytic syndrome following alemtuzumab treatment for multiple sclerosis: A case report

Conclusion: HS is a severe condition marked by an excessive activation of the immune system that leads to a rapid and progressive multi-organ failure, so it is important to consider it in the differential diagnosis of a fever syndrome following the administration of alemtuzumab.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research